Related Experiment Video
Updated: Jun 23, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Role of MAPKs in platinum-induced neuronal apoptosis
Arianna Scuteri1, Alessia Galimberti, Daniele Maggioni
1Dipartimento di Neuroscienze e Tecnologie Biomediche, Università degli Studi di Milano-Bicocca, Monza, Italy. arianna.scuteri@unimib.it
Abstract:
An unsolved question is how platinum derivatives used for solid cancer therapy cause peripheral neuropathy in patients and apoptosis in "in vitro" models of chemotherapy-induced peripheral neuropathy. DRG neurons from E15 rat embryos were treated with toxic doses of oxaliplatin or cisplatin. Here, the role of MAPKs in neuronal apoptosis was studied. Both oxaliplatin and cisplatin induced a dose-dependent neuronal apoptosis, modulated by the proteins of Bcl-2 family. Regarding MAPKs, platinum derivatives activated p38 while they reduced the active form and the total amount of JNK/Sapk. Both oxaliplatin and cisplatin activated ERKs at early stages, although they behaved differently at later stages. By using specific inhibitors of the various MAPKs it was demonstrated that the platinum-induced neuronal apoptosis is mediated by early p38 and ERK1/2 activation, while JNK/Sapk has a neuroprotective role. These results suggest a role for the different MAPKs in peripheral neuropathies characterized by apoptosis of DRG neurons.
Insights
Platinum chemotherapy drugs cause nerve damage by inducing apoptosis in sensory neurons. Specific mitogen-activated protein kinases (MAPKs) like p38 and ERK1/2 mediate this damage, while JNK/Sapk plays a protective role.
Area of Science:
- Neuroscience
- Oncology
- Pharmacology
Background:
- Platinum derivatives (oxaliplatin, cisplatin) are vital in solid cancer therapy.
- Chemotherapy-induced peripheral neuropathy (CIPN) is a common, dose-limiting side effect.
- The precise mechanisms of platinum-induced neuronal apoptosis remain incompletely understood.
Purpose of the Study:
- To investigate the role of mitogen-activated protein kinases (MAPKs) in platinum-induced apoptosis of dorsal root ganglion (DRG) neurons.
- To elucidate the specific signaling pathways involved in chemotherapy-induced peripheral neuropathy.
Main Methods:
- DRG neurons from E15 rat embryos were exposed to toxic doses of oxaliplatin or cisplatin.
- Western blotting and specific MAPK inhibitors were used to analyze MAPK activation and function.
- Bcl-2 family protein modulation was assessed in relation to apoptosis.
Main Results:
- Both oxaliplatin and cisplatin induced dose-dependent neuronal apoptosis, modulated by Bcl-2 family proteins.
- Platinum agents activated p38 and early ERK1/2, while reducing JNK/Sapk.
- Inhibition studies revealed p38 and ERK1/2 activation mediate apoptosis, whereas JNK/Sapk exhibits neuroprotection.
Conclusions:
- MAPK signaling pathways differentially regulate platinum-induced DRG neuron apoptosis.
- Early p38 and ERK1/2 activation are key mediators of CIPN.
- JNK/Sapk signaling may represent a potential therapeutic target for mitigating platinum neurotoxicity.
More Related Videos
Related Concept Videos
MAPK Signaling Cascades
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cellular Injury V: Apoptosis and Autophagy
PI3K/mTOR/AKT Signaling Pathway
Microtubule Associated Proteins (MAPs)

